Bluejay Diagnostics, Inc. (BJDX) vs VivoSim Labs, Inc. (VIVS)
A side-by-side comparison of Bluejay Diagnostics, Inc. and VivoSim Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BJDX
Bluejay Diagnostics, Inc.
$0.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VIVS
VivoSim Labs, Inc.
$0.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BJDX vs VIVS
growth of $100 · dividends reinvested · last 1yBJDX -91.4% (-91.4%/yr)VIVS -88.0% (-88.0%/yr)VIVS compounded faster over this window
BJDX VIVS
BJDX vs VIVS: by the numbers
- •BJDX is the larger company ($838843 vs $518606 market cap).
- •Both run net losses; BJDX's is the smaller (0.00% vs -11016.07% net margin).
Metrics side by side
Valuation
| Metric | BJDX | VIVS |
|---|---|---|
| P/S ratio | N/A | 4.63 |
| P/B ratio | 0.09 | N/A |
Profitability
| Metric | BJDX | VIVS |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -8567.94% |
| Net margin | 0.00% | -11016.07% |
| ROE | -77.23% | N/A |
| ROIC | -77.55% | -579.89% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.